Proactive Investors
22 Jul 2026, 06:32 UTC · 9w ago
Verdict
Headline takes no side. We score IMM +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 73% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
ImmuPharma has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment, Kapiglucagon.
More positive than 77% of claims this week
ImmuPharma is pursuing a 505(b)(2) regulatory pathway in the US, which may allow the company to leverage existing safety data rather than repeating full testing.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 63% of claims this week
The company has completed its main manufacturing partnerships for the Kapiglucagon programme after previously selecting Bachem for active ingredient production.
More positive than 50% of claims this week
ImmuPharma is preparing an investigational new drug (IND) application to begin human testing in the United States.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 73% of ticker scores this week
The company has appointed key manufacturing partners and secured funding to advance its diabetes treatment towards clinical development.
More positive than 67% of ticker scores this week
The company received formal government approval for a farm-out deal in Namibia, clearing a final regulatory hurdle.
More positive than 51% of ticker scores this week
The company won a competitive tender to develop and manufacture a drug for ImmuPharma.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
6h ago
MarketBeat
15h ago
—
No price for IMM right now — the quote feed didn't answer.
IMM chart →
